Compare SOJF & BCTXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOJF | BCTXL |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Mining | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2011 | 2025 |
| Metric | SOJF | BCTXL |
|---|---|---|
| Price | $24.89 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.5K | 12.2K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.20 | N/A |
| Revenue | ★ $29,553,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.80 | ★ N/A |
| Revenue Growth | ★ 10.59 | N/A |
| 52 Week Low | $24.65 | $0.61 |
| 52 Week High | $26.35 | $1.40 |
| Indicator | SOJF | BCTXL |
|---|---|---|
| Relative Strength Index (RSI) | 44.21 | 50.85 |
| Support Level | $24.81 | $0.92 |
| Resistance Level | $25.35 | $1.11 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 28.07 | 45.25 |
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.